Universal Scientific Industrial (Shanghai) Co., Ltd.

SHSE:601231 Stock Report

Market Cap: CN¥30.7b

Universal Scientific Industrial (Shanghai) Future Growth

Future criteria checks 3/6

Universal Scientific Industrial (Shanghai) is forecast to grow earnings and revenue by 26.3% and 11.1% per annum respectively. EPS is expected to grow by 26.6% per annum. Return on equity is forecast to be 14.3% in 3 years.

Key information

26.3%

Earnings growth rate

26.6%

EPS growth rate

Electronic earnings growth32.3%
Revenue growth rate11.1%
Future return on equity14.3%
Analyst coverage

Good

Last updated30 Oct 2024

Recent future growth updates

Results: Universal Scientific Industrial (Shanghai) Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Jul 28
Results: Universal Scientific Industrial (Shanghai) Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Earnings Miss: Universal Scientific Industrial (Shanghai) Co., Ltd. Missed EPS By 7.3% And Analysts Are Revising Their Forecasts

Apr 04
Earnings Miss: Universal Scientific Industrial (Shanghai) Co., Ltd. Missed EPS By 7.3% And Analysts Are Revising Their Forecasts

Recent updates

Some Investors May Be Worried About Universal Scientific Industrial (Shanghai)'s (SHSE:601231) Returns On Capital

Nov 21
Some Investors May Be Worried About Universal Scientific Industrial (Shanghai)'s (SHSE:601231) Returns On Capital

Here's Why Universal Scientific Industrial (Shanghai) (SHSE:601231) Can Manage Its Debt Responsibly

Oct 23
Here's Why Universal Scientific Industrial (Shanghai) (SHSE:601231) Can Manage Its Debt Responsibly

Is There An Opportunity With Universal Scientific Industrial (Shanghai) Co., Ltd.'s (SHSE:601231) 48% Undervaluation?

Sep 17
Is There An Opportunity With Universal Scientific Industrial (Shanghai) Co., Ltd.'s (SHSE:601231) 48% Undervaluation?

Universal Scientific Industrial (Shanghai) Co., Ltd. (SHSE:601231) Looks Inexpensive But Perhaps Not Attractive Enough

Aug 19
Universal Scientific Industrial (Shanghai) Co., Ltd. (SHSE:601231) Looks Inexpensive But Perhaps Not Attractive Enough

Results: Universal Scientific Industrial (Shanghai) Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Jul 28
Results: Universal Scientific Industrial (Shanghai) Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Does Universal Scientific Industrial (Shanghai) (SHSE:601231) Have A Healthy Balance Sheet?

Jul 16
Does Universal Scientific Industrial (Shanghai) (SHSE:601231) Have A Healthy Balance Sheet?

Universal Scientific Industrial (Shanghai)'s (SHSE:601231) Dividend Is Being Reduced To CN¥0.27

Jun 02
Universal Scientific Industrial (Shanghai)'s (SHSE:601231) Dividend Is Being Reduced To CN¥0.27

Returns On Capital Signal Tricky Times Ahead For Universal Scientific Industrial (Shanghai) (SHSE:601231)

May 21
Returns On Capital Signal Tricky Times Ahead For Universal Scientific Industrial (Shanghai) (SHSE:601231)

Some Investors May Be Willing To Look Past Universal Scientific Industrial (Shanghai)'s (SHSE:601231) Soft Earnings

Apr 08
Some Investors May Be Willing To Look Past Universal Scientific Industrial (Shanghai)'s (SHSE:601231) Soft Earnings

Earnings Miss: Universal Scientific Industrial (Shanghai) Co., Ltd. Missed EPS By 7.3% And Analysts Are Revising Their Forecasts

Apr 04
Earnings Miss: Universal Scientific Industrial (Shanghai) Co., Ltd. Missed EPS By 7.3% And Analysts Are Revising Their Forecasts

Universal Scientific Industrial (Shanghai) Co., Ltd. (SHSE:601231) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Mar 04
Universal Scientific Industrial (Shanghai) Co., Ltd. (SHSE:601231) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Earnings and Revenue Growth Forecasts

SHSE:601231 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202677,7493,1803,1403,2617
12/31/202570,0762,5692,4004,1588
12/31/202459,8321,7011,5005,6423
9/30/202461,7421,8523,2644,682N/A
6/30/202461,3121,9653,0794,541N/A
3/31/202461,2862,0053,8775,424N/A
12/31/202360,7921,9485,2746,823N/A
9/30/202362,0432,2814,8196,410N/A
6/30/202366,4412,7435,6287,149N/A
3/31/202367,5612,8982,7764,287N/A
12/31/202268,5163,0601,7643,435N/A
9/30/202268,3122,9063721,907N/A
6/30/202261,9672,392-2,132-433N/A
3/31/202258,3192,052-1,011809N/A
12/31/202155,3001,858-2,617-1,102N/A
9/30/202154,7351,861-1,425-186N/A
6/30/202152,9521,785-453690N/A
3/31/202151,0181,793-254891N/A
12/31/202047,6961,7393801,437N/A
9/30/202040,7121,4026271,862N/A
6/30/202039,6171,3789742,011N/A
3/31/202037,1421,2301,1131,870N/A
12/31/201937,2041,2621,7522,426N/A
9/30/201937,3751,263-428194N/A
6/30/201935,3501,177-264290N/A
3/31/201934,9991,216-385150N/A
12/31/201833,5501,180-719-219N/A
9/30/201831,6631,229-88344N/A
6/30/201829,6191,150N/A510N/A
3/31/201829,4621,214N/A1,033N/A
12/31/201729,7061,314N/A1,239N/A
9/30/201727,6891,136N/A1,744N/A
6/30/201726,9501,097N/A1,587N/A
3/31/201725,5521,008N/A2,055N/A
12/31/201623,984806N/A1,600N/A
9/30/201624,205775N/A2,175N/A
6/30/201624,794736N/A2,266N/A
3/31/201626,639688N/A983N/A
12/31/201527,260761N/A846N/A
9/30/201524,322711N/A-578N/A
6/30/201521,314646N/A-444N/A
3/31/201517,920701N/A324N/A
12/31/201415,873701N/A963N/A
9/30/201415,274676N/A1,132N/A
6/30/201414,744643N/A948N/A
3/31/201414,236556N/A1,170N/A
12/31/201314,272564N/A1,326N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 601231's forecast earnings growth (26.3% per year) is above the savings rate (2.8%).

Earnings vs Market: 601231's earnings (26.3% per year) are forecast to grow faster than the CN market (26.2% per year).

High Growth Earnings: 601231's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 601231's revenue (11.1% per year) is forecast to grow slower than the CN market (13.9% per year).

High Growth Revenue: 601231's revenue (11.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 601231's Return on Equity is forecast to be low in 3 years time (14.3%).


Discover growth companies